14-day Premium Trial Subscription Try For FreeTry Free

Here's Why You Should Retain MarketAxess (MKTX) Stock Now

04:10pm, Tuesday, 13'th Dec 2022 Zacks Investment Research
MarketAxess (MKTX) keeps enhancing its product portfolio, which can lead to higher bond trading volumes.

Euronet's (EEFT) epay Takes UnionPay QR Code Payments to Europe

03:51pm, Monday, 12'th Dec 2022 Zacks Investment Research
UnionPay International strikes a deal with Euronet's (EEFT) epay for its strong distribution network.

Why You Should Hold on to Marsh & McLennan (MMC) Stock for Now

02:29pm, Friday, 09'th Dec 2022 Zacks Investment Research
As economies around the world are recovering, Marsh & McLennan's (MMC) Consulting business is likely to flourish.

CNO Financial (CNO) Rises 24.9% in 3 Months: More Growth Ahead?

03:05pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
CNO Financial's (CNO) declining costs are helping the company boost its bottom line.

Marsh & McLennan (MMC) Unit Buys McDonald Zaring in Washington

04:00pm, Monday, 05'th Dec 2022 Zacks Investment Research
Marsh & McLennan's (MMC) business, Marsh, is likely to gain from the McDonald Zaring acquisition through its subsidiary Marsh McLennan Agency.

10 Best Stocks to Buy Now in December

09:15pm, Thursday, 01'st Dec 2022 The Motley Fool
These beaten-down stocks have significant upside.

PRA Group (PRAA) Concludes Refinancing $750M Revolving Credit

01:07pm, Tuesday, 29'th Nov 2022 Zacks Investment Research
PRA Group's (PRAA) Europe revolving credit facility refinancing is expected to improve its balance sheet and capital position.

Employers Holdings (EIG) OKs 2nd Special Cash Dividend for 2022

03:15pm, Wednesday, 23'rd Nov 2022 Zacks Investment Research
Employers Holdings (EIG) plans to return $119 million in capital to shareholders this year.

Should You Hold Euronet Worldwide (EEFT) Stock for Now?

02:40pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Euronet Worldwide's (EEFT) geographic and product-diverse business is expected to play a crucial role in generating growth going ahead.
Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac

Why XP Stock Was Rocketing Higher on Wednesday

05:42pm, Wednesday, 09'th Nov 2022 The Motley Fool
Third-quarter earnings rose higher for the investment management firm.
Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares jumped 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session. Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) sh

Why XP Stock Was Rocketing Higher on Wednesday

12:42pm, Wednesday, 09'th Nov 2022
Third-quarter earnings rose higher for the investment management firm.

XP Inc. (XP) Q3 2022 Earnings Call Transcript

01:57am, Wednesday, 09'th Nov 2022
XP Inc. (NASDAQ:XP ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Andre Martins - Head of Investor Relations Bruno Constantino - Chief Financial Officer Conference
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE